pyrroles has been researched along with oxyntomodulin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ber, E; Cascieri, MA; Chicchi, GG; de Laszlo, SE; Hacker, C; Hagmann, WK; Koch, GE; Louizides, D; MacCoss, M; Sadowski, SJ; Vicario, PP | 1 |
| Hartmann, B; Holst, JJ; Kissow, H; Orskov, C; Poulsen, SS; Ropke, C; Thulesen, J; Thulesen, S | 1 |
| Deacon, CF; Holst, JJ; Møller, S; Plamboeck, A | 1 |
| Aguilar-Bryan, L; Bryan, J; Crane, A; Hu, M; Nakazaki, M; Seghers, V; Ullrich, S | 1 |
4 other study(ies) available for pyrroles and oxyntomodulin
| Article | Year |
|---|---|
Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor.
Topics: Adenylyl Cyclases; Animals; Cations, Divalent; CHO Cells; Cricetinae; Enzyme Activation; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Hormone Antagonists; Humans; Molecular Structure; Mutation; Peptides; Protein Binding; Pyridines; Pyrroles; Receptors, Glucagon | 1999 |
Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice.
Topics: Animals; Body Weight; Dipeptidyl Peptidase 4; Enzyme Inhibitors; Female; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Humans; Intestines; Mice; Mice, Inbred C57BL; Organ Size; Peptides; Pyrroles; Rats; Rats, Wistar; Recombinant Proteins; Valine | 2000 |
GLP-1-(9-36) amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion.
Topics: Anesthesia; Animals; Blood Glucose; Chloralose; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Infusions, Intravenous; Insulin; Insulin Secretion; Kinetics; Metabolic Clearance Rate; Peptide Fragments; Peptides; Protease Inhibitors; Protein Precursors; Pyrroles; Swine; Valine | 2002 |
cAMP-activated protein kinase-independent potentiation of insulin secretion by cAMP is impaired in SUR1 null islets.
Topics: Animals; ATP-Binding Cassette Transporters; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isoquinolines; Mice; Mice, Knockout; Peptide Fragments; Potassium Channels; Potassium Channels, Inwardly Rectifying; Protein Kinase C; Pyrroles; Receptors, Drug; Reference Values; Sulfonamides; Sulfonylurea Receptors | 2002 |